SCHEMBL798108

SCHEMBL798108

CCC(C)(C)c1ccc(OP(Oc2ccc(C(C)(C)CC)cc2)Oc2ccc(C(C)(C)CC)cc2C(C)(C)CC)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 6/20 0.48
NPSR1 Q6W5P4 5/20 0.48
SMN1; SMN2 Q16637 5/20 0.48
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
ALDH1A1 P00352 1/20 0.48
MAPT P10636 5/20 0.47
HTT P42858 3/20 0.47
UBE2N P61088 2/20 0.47
GLA P06280 1/20 0.47
MITF O75030 1/20 0.44
RAB9A P51151 4/20 0.43
NPC1 O15118 3/20 0.43
RAD52 P43351 2/20 0.40
STAT3 P40763 1/20 0.40
RCE1 Q9Y256 1/20 0.40
APAF1 O14727 1/20 0.40
HSP90AA1 P07900 1/20 0.40
NOD2 Q9HC29 1/20 0.40
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29760902 1.00 MAPK1 (0.48) MAPK1NPSR1SMN1; SMN2MEN1KMT2A
SCHEMBL29760889 1.00 MAPK1 (0.48) MAPK1NPSR1SMN1; SMN2MEN1KMT2A
SCHEMBL798770 1.00 MAPK1 (0.48) MAPK1NPSR1SMN1; SMN2MEN1KMT2A
SCHEMBL29443083 0.92 MAPK1 (0.54) MAPK1NPSR1SMN1; SMN2MEN1KMT2A
SCHEMBL133717 0.92 MAPK1 (0.54) MAPK1NPSR1SMN1; SMN2MEN1KMT2A
SCHEMBL17552973 0.88 MAPT (0.43) MAPK1NPSR1SMN1; SMN2MEN1KMT2A
SCHEMBL23473463 0.87 MAPT (0.40) MAPK1NPSR1SMN1; SMN2MEN1KMT2A
SCHEMBL27871281 0.86 MAPK1 (0.49) MAPK1NPSR1SMN1; SMN2MEN1KMT2A
SCHEMBL9350328 0.84 MAPK1 (0.46) MAPK1NPSR1SMN1; SMN2MEN1KMT2A
SCHEMBL561194 0.84 NPC1 (0.56) ALDH1A1MAPTRAB9ANPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4460538-B1 ONE-COMPONENT EXPANDABLE THERMOSETTING EPOXY COMPOSITION WITH IMPROVED STORAGE STABILITY SIKA TECH AG (CH) 2026-02-11 EP claimed
EP-3794066-B1 POLYMER COMPOSITION WITH IMPROVED BARRIER PROPERTIES VERSALIS SPA (IT) 2024-09-11 EP claimed
US-20180237557-A1 POLYETHYLENE POWDER, PROCESS FOR ITS PREPARATION AND ITS USE FOR ROTOMOLDING VERSALIS S.P.A. (IT) 2018-08-23 US claimed
EP-2459574-B1 SOLID ALKYLARYL PHOSPHITE COMPOSITIONS AND METHODS FOR MANUFACTURING SAME ADDIVANT SWITZERLAND GMBH (CH) 2018-06-20 EP claimed
EP-3330343-A1 PHOSPHITE ESTER COMPOSITION Sumitomo Chemical Company, Ltd. (JP) 2018-06-06 EP claimed
EP-2057222-B1 LIQUID PHOSPHITE BLENDS AS STABILIZERS ADDIVANT SWITZERLAND GMBH (CH) 2014-03-12 EP claimed
US-8309635-B2 Solid alkylaryl phosphite compositions and methods for manufacturing same CHEMTURA CORPORATION (US) 2012-11-13 US claimed
WO-2026104401-A1 FUNCTIONALIZED AMINOSILANE IN THE MANUFACTURE OF POLYMERS SYNTHOS DWORY 7 SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (PL) 2026-05-21 WO disclosed
EP-4741404-A1 FUNCTIONALIZED AMINOSILANE IN THE MANUFACTURE OF POLYMERS Synthos Dwory 7 spolka z ograniczona odpowiedzialnoscia (PL) 2026-05-13 EP disclosed
US-20260103482-A1 STABILIZER, ORGANIC MATERIAL COMPOSITION, AND METHOD FOR STABILIZING ORGANIC MATERIAL SUMITOMO CHEMICAL CO (JP) 2026-04-16 US disclosed
EP-4696740-A1 ENVIRONMENTALLY FRIENDLY PROCESSING AID BASED ON A FATTY ACID SALT BASF SE (DE) 2026-02-18 EP disclosed
EP-4688936-A1 THERMOPLASTIC POLYMER COMPOSITIONS CONTAINING STABILISER MIXTURES BASF SE (DE) 2026-02-11 EP disclosed
EP-4460538-B1 ONE-COMPONENT EXPANDABLE THERMOSETTING EPOXY COMPOSITION WITH IMPROVED STORAGE STABILITY SIKA TECH AG (CH) 2026-02-11 EP disclosed
EP-2616473-A2 PHOSPHORUS-CONTAINING MIXTURES, PROCESSES FOR PREPARING THEM AND USE THEREOF Clariant Finance (BV) Limited (VG) 2013-07-24 EP disclosed
US-20130172457-A1 Phosphorus-Containing Mixtures, Processes for Preparing Them and Use Thereof CLARIANT FINANCE (BVI) LIMITED (VG) 2013-07-04 US disclosed
EP-2459575-A2 HYDROLYTICALLY STABLE PHOSPHITE COMPOSITIONS Chemtura Corporation (US) 2012-06-06 EP disclosed
WO-2012034680-A2 PHOSPHORUS-CONTAINING MIXTURES, PROCESSES FOR PREPARING THEM AND USE THEREOF CLARIANT INTERNATIONAL LTD (CH) 2012-03-22 WO disclosed
US-8048946-B2 Hydrolytically stable phosphite compositions CHEMTURA CORPORATION (US) 2011-11-01 US disclosed
WO-2011014529-A2 HYDROLYTICALLY STABLE PHOSPHITE COMPOSITIONS CHEMTURA CORPORATION (US) 2011-02-03 WO disclosed
US-20110028619-A1 Hydrolytically stable phosphite compositions SI GROUP, INC. 2011-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260103482-A1 STABILIZER, ORGANIC MATERIAL COMPOSITION, AND METHOD FOR STABILIZING ORGANIC MATERIAL HNRNPL, APOL1, OR10J3 MAPK1 3912/4885NPSR1 3847/4885SMN1; SMN2 1683/4885
US-20130172457-A1 Phosphorus-Containing Mixtures, Processes for Preparing Them and Use Thereof C9, PHOSPHO1, C5 MAPK1 1024/4885NPSR1 896/4885SMN1; SMN2 1768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.